Pazopanib (GW786034)

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
62043
Phase II study of GW786034 in patients with relapsed or refractory soft tissue sarcoma
08092
Double blind randomized phase III study of maintenance Pazopanib versus placebo in NSCLC patients non progressive after first line chemotherapy.
62072
A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy.

Back to Protocol section